While 34% of all GLP-1 users report dining out less frequently, the picture looks strikingly different among younger users
In cases of severe or refractory constipation, a short course of a stimulant laxative may be warranted, but this should be used judiciously and under medical supervision
1 To better understand the potential relationship between GLP-1 medications and mental health diagnoses after starting the medications, we studied 3,081,254 diabetic patients and 929,174 non-diabetic patients
Additional considerations have recently emerged over the off-label prescribing of medications for weight loss on whether the risk outweighs the benefits
For example, a meta-analysis demonstrated that GLP-1RAs reduced the risk of recurrent AF over a 12-month follow-up in patients undergoing AF catheter ablation, on the basis of data primarily from United States cohorts [32]